ASP Isotopes announced its first-ever Capital Markets Day in London on September 8 to provide an overview of its strategy in critical materials. The event will focus on nuclear medicine, electronic gases, and nuclear fuels, and is intended to bolster investor interest in its proprietary isotope enrichment technologies.